Eurointervention

Papers
(The H4-Index of Eurointervention is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity203
In search of the origin of the acronym TAVI167
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis151
Double-tap to treat paravalvular leak in high-risk annuli144
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation120
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry100
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement83
Transcatheter left ventriculoplasty71
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s71
Recanalisation of coronary chronic total occlusions61
Defer-based non-stenting: a promising approach for STEMI60
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure55
The “road travelled”: reflections on the transformation of information exchange in a digital age55
   Atrial fibrillation and acute coronary syndrome 51
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study49
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve49
One-month DAPT after acute coronary syndrome: too short or not too short?49
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection45
Hybrid coronary revascularisation: the best or the worst of both worlds?41
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document40
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudy39
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD36
Redo transcatheter mitral valve replacement in mitral annular calcification36
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes36
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial36
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement34
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study34
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons32
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study31
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial31
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation30
0.45251512527466